The APPG welcomes the invaluable support of selected organisations who share our aim to promptly deliver the health benefits of more personalised medicine arising from new bioscience & technology to the NHS, for the benefit of patients and the UK population. These organisations understand that we do not endorse, support, lobby for or campaign on behalf of one organisation, and respect the importance of our commitment to transparency across all our activities.
The PHG Foundation is an independent, non-profit health policy think-tank based in Cambridge. Our mission is making science work for health – promoting the fair and effective translation of the best 21st century scientific innovations into improved health policy and practice, and putting bioscience within the reach of individuals and populations via effective, affordable and more personalised healthcare.
BMJ advances healthcare worldwide by sharing knowledge and expertise to improve experiences, outcomes and value. Along with our world renowned flagship title, The BMJ, we also publish over 60 specialty journals and a world-leading collection of digital professional development resources. Our unique digital tools help healthcare professionals support their decisions, interpret clinical data and improve the quality of healthcare delivery.
The Wellcome Trust Sanger Institute is a leading research institute dedicated to genomic research. The charitably-funded Institute was a pivotal partner in the Human Genome Project and its continuing mission is to produce and share research, data and resources that can be used for diagnostics and therapies that reduce global health burdens.
The Northern Health Science Alliance Ltd (NHSA) is a health partnership established by the leading Universities, NHS Hospital Trusts and AHSNs in the North of England to improve the health and wealth of the region by creating an internationally recognised life science and healthcare system. The NHSA is globally unique in its approach, linking eight universities and eight teaching Trusts that encompass a patient population of over 15 million people. It is an exciting opportunity to recognise and promote the value of the North of England and Northern Powerhouse to the global Innovation, Health and Wealth agenda.
What the partners say
“Opportunities for bioscience and technology to transform healthcare and deliver better health via personalised medicine are rapidly expanding, and we are delighted to provide the secretariat to this significant new parliamentary group as they examine these opportunities and consider how to ensure that patients and populations get the greatest health benefits from them.”
Dr Hilary Burton, Director, PHG Foundation
"BMJ has been at the forefront of innovative healthcare thinking and practice since 1840, and is committed to promoting innovation in healthcare to help improve outcomes for patients throughout the world. We are very proud to become a formal partner in the All-Party Parliamentary Group on Personalised Medicine and we look forward to contributing to this important and exciting area of medicine."
Matthew Harker, Director of Evidence and Analytics, BMJ
The Wellcome Trust Sanger Institute is excited to be involved in this important All-Party Parliamentary Group, which we believe will help ensure that the UK's established scientific capabilities are translated into a world-leading healthcare revolution and put patients at the heart of the UK healthcare system."
Dr Julia Wilson, Associate Director External Relations, Wellcome Trust Sanger Institute
Dr Hakim Yadi, Chief Executive, Northern Health Science Alliance